MedTrace Logo

Efficacy of Topical Cyclosporin for Ocular Rosacea

NCT00348335 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2011-07-29

No results posted yet for this study

Summary

The purpose of this study is to determine whether Restasis (topical cyclosporin) is effective in the treatment of ocular rosacea

Conditions

  • Rosacea

Interventions

DRUG

Cyclosporine 0.05%

DRUG

Ocular lubricant

Sponsors & Collaborators

  • Allergan

    collaborator INDUSTRY

  • Ophthalmic Consultants of Long Island

    lead OTHER

Principal Investigators

  • John R Wittpenn, MD · Ophthalmic Consultants of Long Island

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-06-30
Primary Completion
2007-09-30
Completion
2007-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00348335 on ClinicalTrials.gov